J clin oncol 2013 31:845-852

Author: uoso

August undefined, 2024

http://www.zlfzyj.com/CN/abstract/abstract10225.shtml Web摘要由于下咽独特的位置与功能，器官功能的保全与生存的提高同样重要，对于下咽癌的最佳保喉策略在持续探索中。手术、放疗、化疗、分子靶向治疗以及免疫治疗等手段的不断进步，新的保喉治疗策略不断涌现。本文主要介绍下咽癌保喉治疗策略的确立、发展以及对未来 …

Concomitant Systemic and Radiotherapy Treatment of Head and …

WebNov 1, 2013 · J Clin Oncol. 2013 Nov 1;31 (31):3980-6. doi: 10.1200/JCO.2013.49.9202. Epub 2013 Sep 23. Authors Hany Soliman 1 , Jolie Ringash , Haiyan Jiang , Kawalpreet Singh , John Kim , Robert Dinniwell , Anthony Brade , Rebecca Wong , James Brierley , Bernard Cummings , Camilla Zimmermann , Laura A Dawson Affiliation WebKey Points. Question Is the addition of concomitant systemic treatment to definitive radiotherapy associated with longer survival in older patients with locoregionally advanced head and neck squamous cell carcinoma?. Findings In this cohort study of 1044 older adults (aged ≥65 years) with head and neck squamous cell carcinoma, overall survival and … earl liverpool

Head and Neck Cancer NEJM - New England Journal of …

WebLancet Oncol. 2011;12(9):852–861. 80. Ledermann J, Harter P, Gourley C, et al. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. ... J Clin Oncol. 2012;30(31):3841–3847. 97. Campos SM, Penson RT, Matulonis U, et al. A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and ... Web1. Introduction. Alcohol-dependent liver disease (ALD) manifests as progressively worsening liver health following heavy ethanol (EtOH) ingestion, usually occurring over a period of … WebDer Übersichtsartikel stellt verschiedene Techniken vor, wie 3‑D-organotypische Modelle, patientenabgeleitete Xenograftmodelle (PDX), organotypische multizelluläre Sphäroide und Ex-vivo-Gewebekulturen, die Tumor- wie Stromazellen gleichermaßen repräsentieren, und diskutiert Vor- und Nachteile in Bezug auf die Translation in die klinische Praxis. earl livings the silence inside the world

Comparison of Carboplatin With Cisplatin in Small Cell Lung …

Contemporary Multidisciplinary Management of Sinonasal …

WebIntroduction. Sinonasal mucosal melanoma (SNMM) is a rare tumor, comprising about 1% of all melanomas and about 4–8% of sinonasal malignancies. 1,2 In recent years, SNMM has been considered and managed as a separate disease from cutaneous melanoma, including its staging system and treatment modalities. 3 SNMM most commonly affects the nasal … WebJ Clin Oncol. 2013;31 (7):845-852. Epub 2012 Nov 26. Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx. Acta Otolaryngol. 2013;133 (6):633-640. Epub 2013 Feb 11. Gold KA, Lee HY, Kim ES. css inline block heightWebJ Clin Oncol 2013;31: 845-852. Crossref; Web of Science; ... J Clin Oncol 2013;31: 2854-2860. Crossref; Web of Science; Medline; Google Scholar. 56. Lorch JH, Posner MR, Wirth … earl lollis meyers

"WebApr 4, 2024 · J Clin Oncol. 2013;31:845-852. 5. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of … " - J clin oncol 2013 31:845-852

J clin oncol 2013 31:845-852

Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lun…

WebJ Clin Oncol. 2013;31 (7):845-852. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57 (1):49-60. WebOct 1, 2024 · J Clin Oncol. 2013; 31: 845-852. Crossref; PubMed; Scopus (816) Google Scholar]. Nevertheless, PF-based IC + RT was superior to CRT by causing less severe late toxicity, and increasing laryngectomy-free survival (LFS) due to fewer non-cancer deaths as shown in the RTOG 91-11 trial [4. Forastiere A.A.

Did you know?

WebApr 28, 2024 · Oral cavity squamous cell carcinoma (OCSCC) is not an uncommon cancer, with approximately 30,260 new cases and 6650 deaths reported annually in the United … WebSpine 2010 35 E1221E1229 CrossRef 78 Avrahami E Tadmor R Dally O Hadar H Early from PHYS 111 at University of Toronto

WebNov 2, 2015 · Either an increase or decrease in the immunoreactivity to GABA(A) alpha-1 subunit was observed in some patients. 31 Others have found more consistent decreases in GABAergic neurons in the peritumoral tissue identified as epileptogenic by electrocorticography as compared with normal tissue. 32 Autoradiographic studies of …

WebNov 1, 2013 · Journal of Clinical Oncology: Vol 31, No 31 Vol. 31, No. 31, November 1, 2013 EDITORIALS Marriage Is As Protective As Chemotherapy in Cancer Care Kissane pp. … WebNov 9, 2024 · Summary of Evidence. Background. In 2024, over 160,000 men in the United States (U.S.) were diagnosed with prostate cancer, which accounted for 9.6% of all new cancer diagnoses. 1 Clinically localized prostate cancer accounts for ~80% of newly diagnosed cases. 1 The NCCN, classifies these men into risk groups based on clinical and …

WebDec 15, 2015 · J Hematol Oncol. 2024 Sep 8;14(1):140. doi: 10.1186/s13045-021-01144-9. Westin JR, Kersten MJ, Salles G, Abramson JS, Schuster SJ, Locke FL, Andreadis C. …

WebMay 21, 2015 · Despite advances in the development of molecularly targeted therapies, limited improvements in overall survival have been noted among many cancer patients with solid tumors, primarily due to development of drug resistance. Accordingly, there is an unmet need for new targeted therapies and treatment approaches for cancer, especially … earl lmhWebCancer Research on Prevention and Treatment 2024, Vol. 50 Issue (04): 327-333 DOI: 10.3971/j.issn.1000-8578.2024.22.1296 Progress on Multi-disciplinary Combined Therapy for Locally Advanced Hypopharyngeal Carcinoma. LUO Xi, YI Junlin: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer ... css inline-block marginWebJan 1, 2003 · Purpose: The Head and Neck Intergroup conducted a phase III randomized trial to test the benefit of adding chemotherapy to radiation in patients with unresectable … earll kingston actorWebApr 2, 2024 · We identified 63 eligible clinical studies that focussed on recurrence and survival. Studies assessed investigated various ctDNA biomarkers in patients with different stages of cancer undergoing surgical resection, chemotherapy and no treatment. earl locklear ncdotWebSep 1, 2013 · Objectives were to determine: one, rate of complete response (CR) after remission induction therapy with methotrexate, temozolomide, and rituximab (MT-R); two, feasibility of a two-step approach using high-dose consolidation with etoposide plus cytarabine (EA); three, progression-free survival (PFS); and four, correlation between … css inline-block not workingWebPurpose To report the long-term results of the Intergroup Radiation Therapy Oncology Group 91-11 study evaluating the contribution of chemotherapy added to radiation therapy (RT) for larynx preservation. earl lordeyWebJ Clin Oncol. 2024; 36 (31): 3077–83 CrossRef Geoffrois L et al. Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the GORTEC 2007-02 phase III randomized trial. J Clin Oncol. 2024; 36 (31): 3077–83 CrossRef earl lockwood cloudy 2013